← Back to Screener
Genenta Science S.p.A. American Depositary Shares (GNTA)
Price$0.70
Favorite Metrics
Price vs S&P 500 (26W)-86.29%
Price vs S&P 500 (4W)6.25%
Market Capitalization$19.95M
All Metrics
Book Value / Share (Quarterly)$0.75
P/TBV (Annual)2.70x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.60
Price vs S&P 500 (YTD)-55.15%
EPS (TTM)$-0.55
10-Day Avg Trading Volume0.05M
EPS Excl Extra (TTM)$-0.55
EPS (Annual)$-0.57
ROI (Annual)-71.32%
Cash / Share (Quarterly)$1.09
ROA (Last FY)-60.12%
EBITD / Share (TTM)$-0.52
ROE (5Y Avg)-41.34%
Cash Flow / Share (Annual)$-0.40
P/B Ratio1.19x
P/B Ratio (Quarterly)4.09x
Net Income / Employee (Annual)$-1
Net Interest Coverage (TTM)-552.00x
ROA (TTM)-47.83%
EPS Incl Extra (Annual)$-0.57
Current Ratio (Annual)6.89x
Quick Ratio (Quarterly)12.80x
3-Month Avg Trading Volume0.75M
52-Week Price Return8.29%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.75
52-Week High$10.00
EPS Excl Extra (Annual)$-0.57
26-Week Price Return-77.54%
Quick Ratio (Annual)6.84x
13-Week Price Return-46.72%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)13.20x
Enterprise Value$19.759
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.82
3-Month Return Std Dev109.22%
Net Income / Employee (TTM)$-1
ROE (Last FY)-71.32%
Net Interest Coverage (Annual)-7.46x
EPS Basic Excl Extra (Annual)$-0.57
Receivables Turnover (TTM)0.00x
Total Debt / Equity (Quarterly)0.62x
EPS Incl Extra (TTM)$-0.55
Receivables Turnover (Annual)0.00x
ROI (TTM)-54.10%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$2.20
Price vs S&P 500 (52W)-4.86%
Year-to-Date Return-51.01%
5-Day Price Return13.59%
EPS Normalized (Annual)$-0.57
ROA (5Y Avg)-36.67%
Month-to-Date Return8.63%
Cash Flow / Share (TTM)$-0.92
EBITD / Share (Annual)$-0.59
ROI (5Y Avg)-41.34%
LT Debt / Equity (Quarterly)0.62x
EPS Basic Excl Extra (TTM)$-0.55
P/TBV (Quarterly)3.39x
P/B Ratio (Annual)5.41x
Book Value / Share (Annual)$0.80
Price vs S&P 500 (13W)-49.59%
Beta0.84x
Revenue / Share (TTM)$0.00
ROE (TTM)-70.71%
52-Week Low$0.59
Industry Peers — Biological Products(89)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
GNTAGenenta Science S.p.A. American Depositary Shares | — | — | — | — | $0.70 |
AMGNAmgen Inc | 5.20x | 9.95% | 73.30% | 2.93% | $350.16 |
GILDGilead Sciences Inc | 5.71x | 2.40% | 78.83% | 133.64% | $135.87 |
ARGXargenx SE American Depositary Shares | 12.59x | 89.56% | 150.91% | — | $834.45 |
BNTXBioNTech SE American Depositary Share | 9.06x | -11.81% | 84.21% | — | $105.19 |
BIIBBiogen Inc. Common Stock | 2.72x | 2.22% | 75.69% | -18.77% | $183.34 |
MRNAModerna, Inc. Common Stock | 10.91x | -39.93% | 70.32% | — | $54.59 |
NBIXNeurocrine Biosciences Inc | 4.64x | 21.45% | 98.18% | 2.31% | $131.59 |
EXELExelixis Inc | 4.89x | 6.85% | 96.39% | 31.10% | $43.61 |
TECHBio-Techne Corp. | 7.72x | 1.64% | 66.60% | -20.58% | $60.58 |
IBRXImmunityBio, Inc. Common Stock | 74.42x | 668.31% | 99.34% | — | $8.20 |
About
Genenta Science is a clinical-stage biotechnology company developing hematopoietic stem cell gene therapies for solid tumors. Its pipeline includes Temferon, a therapeutic candidate designed to treat glioblastoma multiforme, an aggressive form of brain cancer.